ATE531766T1 - Hochreine texaphyrinmetallkomplexe - Google Patents

Hochreine texaphyrinmetallkomplexe

Info

Publication number
ATE531766T1
ATE531766T1 AT05807302T AT05807302T ATE531766T1 AT E531766 T1 ATE531766 T1 AT E531766T1 AT 05807302 T AT05807302 T AT 05807302T AT 05807302 T AT05807302 T AT 05807302T AT E531766 T1 ATE531766 T1 AT E531766T1
Authority
AT
Austria
Prior art keywords
metal complexes
texaphyrin metal
compositions
high purity
purity texaphyrin
Prior art date
Application number
AT05807302T
Other languages
English (en)
Inventor
Hugo Madden
Greg Hemmi
Tarak Mody
Original Assignee
Pharmacyclics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacyclics Inc filed Critical Pharmacyclics Inc
Application granted granted Critical
Publication of ATE531766T1 publication Critical patent/ATE531766T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0076PDT with expanded (metallo)porphyrins, i.e. having more than 20 ring atoms, e.g. texaphyrins, sapphyrins, hexaphyrins, pentaphyrins, porphocyanines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/27Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups
    • C07C205/35Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C205/36Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system
    • C07C205/37Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by etherified hydroxy groups having nitro groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton to carbon atoms of the same non-condensed six-membered aromatic ring or to carbon atoms of six-membered aromatic rings being part of the same condensed ring system the oxygen atom of at least one of the etherified hydroxy groups being further bound to an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B47/00Porphines; Azaporphines
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00Dyes not provided for by a single group of this subclass

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05807302T 2005-09-26 2005-09-26 Hochreine texaphyrinmetallkomplexe ATE531766T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2005/034684 WO2007040506A1 (en) 2005-09-26 2005-09-26 High-purity texaphyrin metal complexes

Publications (1)

Publication Number Publication Date
ATE531766T1 true ATE531766T1 (de) 2011-11-15

Family

ID=37906444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05807302T ATE531766T1 (de) 2005-09-26 2005-09-26 Hochreine texaphyrinmetallkomplexe

Country Status (10)

Country Link
EP (1) EP1931735B1 (de)
JP (1) JP2009509954A (de)
CN (1) CN101309976B (de)
AT (1) ATE531766T1 (de)
CA (1) CA2623334C (de)
DK (1) DK1931735T3 (de)
ES (1) ES2376581T3 (de)
HK (1) HK1120065A1 (de)
PL (1) PL1931735T3 (de)
WO (1) WO2007040506A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5685232B2 (ja) * 2012-09-07 2015-03-18 ファーマサイクリクス,インコーポレイテッド 高純度テキサフィリン金属錯体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457183A (en) * 1989-03-06 1995-10-10 Board Of Regents, The University Of Texas System Hydroxylated texaphyrins
US5886173A (en) * 1997-07-30 1999-03-23 Pharmacyclics, Inc. Metallation of macrocycles with 2,4-dicarbonyl-metal complexes
BR9912905A (pt) * 1998-08-11 2001-05-08 Ciba Sc Holding Ag Metalocenil-ftalocianinas
WO2001032210A2 (en) * 1999-10-29 2001-05-10 Pharmacyclics, Inc. Compositions for treating atheroma and neoplastic tissue
AU2001288448A1 (en) * 2000-08-30 2002-03-13 Pharmacyclics, Inc. Agents for neutron capture therapy
CA2508724A1 (en) * 2002-12-04 2004-06-17 Pharmacyclics, Inc. Preparation of metallotexaphyrins

Also Published As

Publication number Publication date
CA2623334A1 (en) 2007-04-12
CA2623334C (en) 2013-11-12
WO2007040506A1 (en) 2007-04-12
CN101309976A (zh) 2008-11-19
CN101309976B (zh) 2012-12-12
HK1120065A1 (en) 2009-03-20
PL1931735T3 (pl) 2012-03-30
DK1931735T3 (da) 2012-01-30
EP1931735A4 (de) 2010-07-14
JP2009509954A (ja) 2009-03-12
EP1931735A1 (de) 2008-06-18
ES2376581T3 (es) 2012-03-15
EP1931735B1 (de) 2011-11-02

Similar Documents

Publication Publication Date Title
NO2017019I1 (no) Diarylhydantoinforbindelse, farmasøytisk sammensetning og anvendelse derav
TW200510416A (en) P38 inhibitors and methods of use thereof
DE602004022316D1 (de) Legierungszusammensetzungen und diese enthaltende vorrichtungen
UA86400C2 (ru) Применение эритропоэтина в низком дозировании для пациентов с дисфункцией эндотелиальных клеток-предшественников, сердечно-сосудистым фактором риска и повреждением конечного органа
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
MXPA05009304A (es) Derivados de indol utiles para el tratamiento de enfermedades.
MX2011006959A (es) Compuestos substituidos de 5,6-dihidro-6-fenilbenzo [f] isoquinolina-2-amina.
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
EA201001143A1 (ru) Активаторы прокаспаз "исполнителей" 3, 6 и 7
GEP20125565B (en) Lactam compounds and their pharmaceutical use
WO2006034154A3 (en) Salts of 5-azacytidine
UA101493C2 (ru) Производные азетидина и циклобутана как ингибиторы jak
WO2005004818A3 (en) Heterocyclic compounds and their use as anticancer agents
HK1123282A1 (en) Oxygen linked pyrimidine derivatives
NO20063787L (no) Terapeutiske preparater
MY149957A (en) Heterocyclic inhibitors of mek and methods of use thereof
DE602005002562D1 (de) Pyrrolylsubstituierte pyridoä2,3-düpyrimidin-7-one und derivate davon als therapeutische mittel
MX2008001982A (es) Compuestos nitro-o, sus composiciones farmaceuticas y sus usos.
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
GB0524814D0 (en) Compounds
WO2007076087A3 (en) 3-aryl-substituted quinazolones, and uses thereof
TW200745081A (en) Compounds
MXPA05012894A (es) Benzofuranos 3-sustituidos como agentes terapeuticos.
EP1773363A4 (de) Ngna-zusammensetzungen und anwendungsverfahren
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung